Purchases and Sales Made in Q4 2024 in Heron Therapeutics, Inc. (HRTX)
This table provides information about the institutional ownership of Heron Therapeutics, Inc. (HRTX) during Q4 2024. The information is specifically focused on institutions that hold shares of HERON THERAPEUTICS, INC. .
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-350K- 3.95% |
$371K - $742K
|
8.5M
$19.2M
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-412K- 29.38% |
$437K - $873K
|
990K
$2.24M
|
|
Feb 14, 2025
Q4 2024
|
Clearline Capital LP
New York, NY |
SELL
|
- |
-416K- 18.69% |
$441K - $882K
|
1.81M
$4.09M
|
|
Feb 10, 2025
Q4 2024
|
Monaco Asset Management Sam
|
SELL
|
- |
-466K- 27.74% |
$494K - $987K
|
1.21M
$2.74M
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-563K- 6.45% |
$596K - $1.19M
|
8.16M
$18.4M
|
|
Feb 10, 2025
Q4 2024
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-644K- 12.14% |
$683K - $1.37M
|
4.66M
$10.5M
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-661K- 15.07% |
$701K - $1.4M
|
3.72M
$8.42M
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-685K- 76.12% |
$726K - $1.45M
|
215K
$486K
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-698K- 40.69% |
$740K - $1.48M
|
1.02M
$2.3M
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-719K- 76.93% |
$762K - $1.52M
|
216K
$487K
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-792K- 71.6% |
$840K - $1.68M
|
314K
$710K
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-819K- 40.8% |
$869K - $1.74M
|
1.19M
$2.69M
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.05M- 61.62% |
$1.12M - $2.23M
|
655K
$1.48M
|